HUM · Humana Inc

$362.98 -2.43 (-0.67%)

Market Cap

$43.87B

120.06M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David E. Dintenfass	President, Enterprise Growth	$605,769	$5,684,000	$6,084,670	$4,877,489	$601,407	$208,222	$18,061,557
James Rechtin	CEO	$1,105,769	—	$7,317,483	$4,495,979	$1,943,477	$716,768	$15,579,476
Bruce D. Broussard	CEO	$1,344,231	—	$8,000,037	$0	$2,491,803	$221,093	$12,057,164
Susan Diamond	CFO	$846,192	—	$6,733,897	$948,087	$911,377	$177,961	$9,617,514
Sanjay Shetty	President, CenterWell	$694,808	$550,000	$3,798,420	$623,769	$661,107	$107,159	$6,435,263
George Renaudin II	President, Medicare & Medicaid	$717,885	—	$3,906,380	$661,165	$756,626	$110,025	$6,152,081

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bruce D. Broussard	CEO	$1,469,893	—	$10,898,833	$3,492,874	—	$465,784	$16,327,384
Susan Diamond	CFO	$790,000	—	$2,802,776	$898,145	—	$239,812	$4,730,733
Sanjay Shetty	President, CenterWell	$493,269	$1,400,000	$1,401,072	$449,844	—	$837,756	$4,581,941
Joseph C. Ventura	Chief Legal Officer	$678,000	—	$1,712,892	$548,910	—	$162,359	$3,102,161
George Renaudin II	President, Medicare & Medicaid	$655,000	—	$1,712,892	$548,910	—	$135,676	$3,052,478

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bruce D. Broussard	CEO	$1,349,465	—	$9,638,547	$2,785,410	$3,072,394	$353,028	$17,198,844
Susan Diamond	CFO	$750,000	—	$2,258,317	$652,754	$975,750	$174,177	$4,810,998
T. Alan Wheatley	Segment President, Retail	$665,000	—	$2,180,533	$630,221	$865,165	$131,219	$4,472,138
Timothy S. Huval	Chief Administrative Officer	$663,000	—	$1,596,932	$461,458	$862,563	$150,617	$3,734,570
Joseph C. Ventura	Chief Legal Officer	$600,596	—	$1,596,932	$461,458	$784,147	$155,664	$3,598,797

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bruce D. Broussard	CEO	$1,349,465	—	$9,828,769	$2,779,774	$2,125,407	$444,621	$16,528,036
Brian A. Kane	CFO	$762,116	—	$3,058,073	$864,859	$685,904	$191,220	$5,562,172
T. Alan Wheatley	Segment President, Retail	$657,308	—	$2,192,247	$620,002	$591,577	$161,090	$4,222,224
Susan Diamond	CFO	$640,962	—	$1,861,200	$813,976	$576,866	$168,477	$4,061,481
Timothy S. Huval	Chief Administrative Officer	$660,500	—	$1,616,410	$457,098	$594,450	$173,565	$3,502,023
William K. Fleming	PharmD SegmentPresident, Clinical andPharmacy Solutions	$558,077	—	$1,552,763	$439,191	$502,269	$155,057	$3,207,357

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bruce D. Broussard	CEO	$1,349,465	—	$8,510,832	$2,809,535	$3,292,020	$527,787	$16,489,639
Brian A. Kane	CFO	$750,000	—	$2,647,761	$874,101	$1,045,500	$226,196	$5,543,558
T. Alan Wheatley	Segment President, Retail	$625,000	—	$1,815,538	$599,354	$871,250	$169,064	$4,080,206
Timothy S. Huval	Chief Administrative Officer	$650,000	—	$1,286,194	$424,533	$906,100	$205,608	$3,472,435
William K. Fleming	PharmD SegmentPresident, Clinical andPharmacy Solutions	$550,000	—	$1,361,918	$449,498	$766,700	$185,949	$3,314,065

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bruce D. Broussard	CEO	$1,335,069	—	$8,479,360	$2,814,192	$3,612,030	$485,804	$16,726,455
Brian A. Kane	CFO	$740,577	—	$2,449,601	$813,009	$1,144,933	$233,004	$5,381,124
T. Alan Wheatley	Segment President, Retail	$596,731	—	$1,658,238	$542,620	$922,546	$121,454	$3,841,589
Timothy S. Huval	Chief Administrative Officer	$638,866	—	$1,281,282	$425,238	$987,687	$177,052	$3,510,125
William K. Fleming	PharmD SegmentPresident, Clinical andPharmacy Solutions	$535,866	—	$1,507,517	$493,316	$828,448	$130,851	$3,495,998

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bruce D. Broussard	CEO	$1,273,080	—	$8,610,778	$2,740,664	$3,232,669	$455,326	$16,312,517
Brian A. Kane	Chief Financial Officer	$700,000	—	$2,348,490	$747,426	$1,015,700	$193,409	$5,005,025
Timothy S. Huval	Chief Administrative Officer	$590,921	—	$1,291,525	$411,112	$857,427	$162,451	$3,313,436
William K. Fleming	PharmD SegmentPresident, Clinical andPharmacy Solutions	$475,000	—	$1,548,730	$495,114	$516,919	$120,915	$3,156,678

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bruce D. Broussard	Director, Chief Executive Officer	$1,272,367	—	$10,196,821	$5,279,241	$2,671,970	$348,124	$19,768,525
Brian A. Kane	CFO	$698,779	—	$2,367,097	$1,494,046	$978,291	$120,261	$5,658,476
Timothy S. Huval	Chief Administrative Officer	$590,590	—	$2,029,669	$1,157,928	$826,826	$134,783	$4,739,797

Executive changes

Person	Role	Change	Effective	Filed
Paul J. Smith	directors	Appointed	2026-07-28	2026-07-29
Frederick J. Crawford	directors	Appointed	2026-07-28	2026-07-29
Robert S. Field	director of the Company	Appointed	2026-04-16	2026-04-10

Key facts CIK 49071 CUSIP 444859102 13F (30d) 328 filings 301 filers Visit website Investor relations